Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh

Klaus Unsicker

Jens Pohl

Rolf Bechtold

Michael Paulista

Gertrud Hötten

Gertrud H&ouml;tten

The present invention concerns the use of biologically active MP52 or/and MP121 for the treatment and prevention of diseases of the nervous system or/and for the treatment of neuropathological situations which are caused by ageing of the nervous system. A pharmaceutical agent according to the invention for the treatment and prevention of diseases of the nervous system or/and for treating neuropathological situations which are caused by ageing of the nervous system therefore contains biologically active MP52 or/and MP121 as the active substance.

Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system

The present invention relates to a pharmaceutical composition having neurotrophic activity, comprising a biologically active amount of at least two cytokines, wherein at least one of said cytokines is BMP, GDF, TGF-&bgr; or GDNF.

Cytokines having neurotrophic activity

Use of MP52 or MP121 for treating and preventing diseases of the nervous system

Growing community of inventors

Heidelberg, Germany

Klaus Unsicker